Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 6241 AL 6255

Pathology in primary progressive aphasia syndromes

Harris JM, Jones M.

Curr Neurol Neurosci Rep. 2014 Aug;14(8):466. doi: 10.1007/s11910-014-0466-4.

Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study

Delrieu J, Desmidt T, Camus V, Sourdet S, Boutoleau-Bretonnière C, Mullin E, Vellas B, Payoux P, Lebouvier T; Alzheimer's Disease Neuroimaging Initiative.

Int J Geriatr Psychiatry. 2015 May;30(5):470-7. doi: 10.1002/gps.4161. Epub 2014 Jun 20.

Sex and gender differences in the causes of dementia: a narrative review

Rocca WA, Mielke MM, Vemuri P, Miller VM.

Maturitas. 2014 Oct;79(2):196-201. doi: 10.1016/j.maturitas.2014.05.008. Epub 2014 May 27.

Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease

Fonteh AN, Cipolla M, Chiang J, Arakaki X, Harrington MG.

PLoS One. 2014 Jun 23;9(6):e100519. doi: 10.1371/journal.pone.0100519. eCollection 2014.

Body mass index delineates ALS from FTD: implications for metabolic health

Ahmed RM, Mioshi E, Caga J, Shibata M, Zoing M, Bartley L, Piguet O, Hodges JR, Kiernan MC.

J Neurol. 2014 Sep;261(9):1774-80. doi: 10.1007/s00415-014-7416-6. Epub 2014 Jun 24.

Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia

Van der Mussele S, Le Bastard N, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S.

Aging Ment Health. 2015;19(3):247-57. doi: 10.1080/13607863.2014.924900. Epub 2014 Jun 25.

Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome

Iulita MF, Cuello AC.

Trends Pharmacol Sci. 2014 Jul;35(7):338-48. doi: 10.1016/j.tips.2014.04.010. Epub 2014 Jun 21.

Dementia does not preclude very reliable responding on the MMPI-2 RF: a case report

Carone DA, Ben-Porath YS.

Clin Neuropsychol. 2014;28(6):1019-29. doi: 10.1080/13854046.2014.930182. Epub 2014 Jun 26.

Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study

Freund-Levi Y, Bloniecki V, Auestad B, Tysen Bäckström AC, Lärksäter M, Aarsland D.

Dement Geriatr Cogn Disord. 2014;38(3-4):234-44. doi: 10.1159/000362204. Epub 2014 Jun 25.

Diagnostic accuracy of the Phototest for cognitive impairment and dementia in Argentina

Russo MJ, Iturry M, Sraka MA, Bartoloni L, Carnero Pardo C, Allegri RF.

Clin Neuropsychol. 2014;28(5):826-40. doi: 10.1080/13854046.2014.928748. Epub 2014 Jun 27.

Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study

Ong KT, Villemagne VL, Bahar-Fuchs A, Lamb F, Langdon N, Catafau AM, Stephens AW, Seibyl J, Dinkelborg LM, Reininger CB, Putz B, Rohde B, Masters CL, Rowe CC.

J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):431-6. doi: 10.1136/jnnp-2014-308094. Epub 2014 Jun 26.

Copper mediated neurological disorder: visions into amyotrophic lateral sclerosis, Alzheimer and Menkes disease

Ahuja A, Dev K, Tanwar RS, Selwal KK, Tyagi PK.

J Trace Elem Med Biol. 2015 Jan;29:11-23. doi: 10.1016/j.jtemb.2014.05.003. Epub 2014 Jun 2.

[Treatment of hypertension may affect the incidence of dementia?]

Souček M.

Vnitr Lek. 2014 Apr;60(4):354, 356-8.

Social support group interventions in people with dementia and mild cognitive impairment: a systematic review of the literature

Leung P, Orrell M, Orgeta V.

Int J Geriatr Psychiatry. 2015 Jan;30(1):1-9. doi: 10.1002/gps.4166. Epub 2014 Jul 3.

Translating cognitive and everyday activity deficits into cognitive interventions in mild dementia and mild cognitive impairment

Giebel C, Challis D.

Int J Geriatr Psychiatry. 2015 Jan;30(1):21-31. doi: 10.1002/gps.4170. Epub 2014 Jul 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias